Literature DB >> 11926919

Powered instrumentation in the treatment of recurrent respiratory papillomatosis: an alternative to the carbon dioxide laser.

Mohamed A El-Bitar1, George H Zalzal.   

Abstract

OBJECTIVE: To assess the advantages of powered instrumentation vs the carbon dioxide laser in treating patients with juvenile-onset recurrent respiratory papillomatosis.
DESIGN: A retrospective study.
SETTING: Tertiary care children's hospital. PATIENTS: Patients operated on for juvenile-onset recurrent respiratory papillomatosis between January 1, 1999, and December 31, 2000. Papillomas were excised using the microdebrider in one group and the carbon dioxide laser in the second group.
INTERVENTIONS: Direct laryngoscopy and bronchoscopy, suspension microlaryngoscopy, and excision of papillomas by the carbon dioxide laser or the microdebrider. MAIN OUTCOME MEASURES: Operative time and postoperative complications.
RESULTS: Seventy-three operations were performed (23 with the laser and 50 with the microdebrider). Sixteen patients were included, 10 with active disease and 5 with disease in remission; 1 was lost to follow-up. They had a mean age of 3.75 years, and the male-female ratio was 7:9. The patients presented mostly with hoarseness (13 [81%]). Four (25%) had soft tissue complications with the laser. The microdebrider was less time-consuming than the laser, although those treated with the microdebrider had more active disease. No factor could be used to measure treatment outcome due to disease variability. Those who were older, female, and African American tended to have less severe manifestations of disease.
CONCLUSIONS: The microdebrider proved to be less time-consuming than the carbon dioxide laser when used in patients with juvenile-onset recurrent respiratory papillomatosis. Soft tissue complications were nonexistent. In addition to safety, the microdebrider is more appealing to the surgeon, anesthesiologist, and parents, especially because these children often need subsequent surgical procedures.

Entities:  

Mesh:

Year:  2002        PMID: 11926919     DOI: 10.1001/archotol.128.4.425

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  9 in total

1.  Pneumomediastinum and retroperitoneal air after removal of papillomas with the microdebrider and jet ventilation.

Authors:  H Steven Sims; Keith Lertsburapa
Journal:  J Natl Med Assoc       Date:  2007-09       Impact factor: 1.798

Review 2.  [Current therapeutic options for recurrent respiratory papillomatosis].

Authors:  K Huber; H Sadick; K Götte
Journal:  HNO       Date:  2005-11       Impact factor: 1.284

3.  Risk factors associated with severe recurrent respiratory papillomatosis.

Authors:  Muddaseer Khan; Tesuven K Naidu
Journal:  S Afr J Infect Dis       Date:  2019-11-20

4.  Microdebrider-assisted partial tonsillectomy: short- and long-term outcomes.

Authors:  Mohamed A Bitar; Charbel Rameh
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-02       Impact factor: 2.503

5.  Tracheo-bronchial recurrent respiratory papillomatosis: role of powered instruments in overcoming surgical challenges.

Authors:  Kapil Sikka; Madan Gupta; Hitesh Verma; Rajeev Kumar; Alok Thakar
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-04       Impact factor: 2.124

6.  Laryngeal debridement: an alternative treatment for a laryngopyocele presenting with severe airway obstruction.

Authors:  L Fraser; B Pittore; S Frampton; P Brennan; R Puxeddu
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-02-21       Impact factor: 2.124

Review 7.  Recurrent respiratory papillomatosis: current and future perspectives.

Authors:  Marco Carifi; Domenico Napolitano; Morando Morandi; Danilo Dall'Olio
Journal:  Ther Clin Risk Manag       Date:  2015-05-05       Impact factor: 2.423

Review 8.  Current and future management of recurrent respiratory papillomatosis.

Authors:  Ryan Ivancic; Hassan Iqbal; Brad deSilva; Quintin Pan; Laura Matrka
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-01-14

Review 9.  Surgical treatment and adjuvant therapies of recurrent respiratory papillomatosis.

Authors:  Melissa Ameloti Gomes Avelino; Tallyta Campos Domingues Teixeira Zaiden; Raquel Oliveira Gomes
Journal:  Braz J Otorhinolaryngol       Date:  2013 Sep-Oct
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.